Pharmacological treatments inhibiting levodopa-induced dyskinesias in MPTP-lesioned monkeys: brain glutamate biochemical correlates
Antiglutamatergic drugs can relieve Parkinson’s disease (PD) symptoms and decrease L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesias (LID). This review reports relevant studies investigating glutamate receptor subtypes in relation to motor complications in PD patients and 1-methyl-4-phenyl-1...
Main Authors: | Nicolas eMorin, Thérèse eDi Paolo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-08-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fneur.2014.00144/full |
Similar Items
-
In vivo photometry during movement changes our understanding of the direct and indirect pathways. A commentary on: Cui G, Jun SB, Jin X et al. Concurrent activation of striatal direct and indirect pathways during action initiation. Nature; 494: 238-242.
by: John Joseph Mckinley, et al.
Published: (2013-08-01) -
Dystonia and levodopa-induced dyskinesias in Parkinson's disease: Is there a connection?
by: Paolo Calabresi, et al.
Published: (2019-12-01) -
Direct and Indirect Pathways of the Basal Ganglia: Opponents or Collaborators?
by: Kainan Sally Wang, et al.
Published: (2015-03-01) -
Basal ganglia circuits underlying the pathophysiology of levodopa-induced dyskinesia
by: Pedro eBarroso Chinea, et al.
Published: (2010-09-01) -
Cerebellum in levodopa-induced dyskinesias: the unusual suspect in the motor network
by: Asha eKishore, et al.
Published: (2014-08-01)